CBD2 is an updated database for colorectal cancer (CRC) biomarkers, expanding the original collection to 1569 new biomarkers across DNA, RNA, protein, and more, plus data on non-viable biomarkers. It features network analysis for exploring biomarker relationships and supports queries for chemicals and drug combinations, aiding in polypharmacological treatment design. CBD2 is free to use and aims to enhance CRC research and treatment strategies.
Xueli Zhang, Min Li, Siting Ye, Ke Shen, Haining Yuan, Shoaib Bakhtyar, Qiliang Peng, Yongsheng Liu, Yingying Wang, Manshi Li, Chi Zhang, Yixin Wang, Xiaohe Bai, Shunming Liu, Ke Zhao, Bairong Shen, Dirk Repsilber, Guang Hu, Hong Zhang, Xiao-Feng Sun